Ekatherina S. Kuligina

Saint Petersburg, SPE, Russian Federation

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Pathways and targeting avenues of BRAF in non-small cell lung cancer.

Pathways and targeting avenues of BRAF in non-small cell lung cancer.

Journal: Expert opinion on therapeutic targets
Published: June 28, 2024

Origin of Residual Tumor Masses in BRCA1/2-Driven Ovarian Carcinomas Treated by Neoadjuvant Chemotherapy: Selection of Preexisting BRCA1/2-Proficient Tumor Cells but Not the Gain of Second ORF-Restoring Mutation.

Origin of Residual Tumor Masses in BRCA1/2-Driven Ovarian Carcinomas Treated by Neoadjuvant Chemotherapy: Selection of Preexisting BRCA1/2-Proficient Tumor Cells but Not the Gain of Second ORF-Restoring Mutation.

Journal: Pathobiology : journal of immunopathology, molecular and cellular biology
Published: April 14, 2023

Preparation of Duplex Sequencing Libraries for Archival Paraffin-Embedded Tissue Samples Using Single-Strand-Specific Nuclease P1.

Preparation of Duplex Sequencing Libraries for Archival Paraffin-Embedded Tissue Samples Using Single-Strand-Specific Nuclease P1.

Journal: International journal of molecular sciences
Published: March 26, 2022

Comprehensive evaluation of the test for 5'-/3'-end mRNA unbalanced expression as a screening tool for ALK and ROS1 fusions in lung cancer.

Comprehensive evaluation of the test for 5'-/3'-end mRNA unbalanced expression as a screening tool for ALK and ROS1 fusions in lung cancer.

Journal: Cancer medicine
Published: October 20, 2021

Treating non-small cell lung cancer with selumetinib: an up-to-date drug evaluation.

Treating non-small cell lung cancer with selumetinib: an up-to-date drug evaluation.

Journal: Expert opinion on pharmacotherapy
Published: September 04, 2020

Frequency and molecular characteristics of PALB2-associated cancers in Russian patients.

Frequency and molecular characteristics of PALB2-associated cancers in Russian patients.

Journal: International journal of cancer
Published: June 15, 2020

Systemic investigations into the molecular features of bilateral breast cancer for diagnostic purposes.

Systemic investigations into the molecular features of bilateral breast cancer for diagnostic purposes.

Journal: Expert review of molecular diagnostics
Published: December 15, 2019

Comparative analysis of expression of mutant and wild-type alleles is essential for reliable PCR-based detection of MET exon 14 skipping.

Comparative analysis of expression of mutant and wild-type alleles is essential for reliable PCR-based detection of MET exon 14 skipping.

Journal: Biochimie
Published: July 05, 2019

Principles of clinical management of ovarian cancer.

Principles of clinical management of ovarian cancer.

Journal: Chinese clinical oncology
Published: September 26, 2018

First-Line Cetuximab Monotherapy in KRAS/NRAS/BRAF Mutation-Negative Colorectal Cancer Patients.

First-Line Cetuximab Monotherapy in KRAS/NRAS/BRAF Mutation-Negative Colorectal Cancer Patients.

Journal: Clinical drug investigation
Published: February 23, 2018

Detection of BRCA1 gross rearrangements by droplet digital PCR.

Detection of BRCA1 gross rearrangements by droplet digital PCR.

Journal: Breast cancer research and treatment
Published: June 15, 2017

Rapid selection of BRCA1-proficient tumor cells during neoadjuvant therapy for ovarian cancer in BRCA1 mutation carriers.

Rapid selection of BRCA1-proficient tumor cells during neoadjuvant therapy for ovarian cancer in BRCA1 mutation carriers.

Journal: Cancer letters
Published: March 06, 2017
Showing 1-12 of 22

Last Updated: 09/26/2026